Csaba Szabo Selected Research

Csaba Szabo Research Topics

Disease

34	Neoplasms (Cancer) 04/2024 - 09/2005
32	Inflammation (Inflammations) 09/2022 - 05/2002
23	Burns 01/2019 - 07/2003
19	Sepsis (Septicemia) 01/2022 - 09/2002
16	Colonic Neoplasms (Colon Cancer) 10/2022 - 07/2013
16	Reperfusion Injury 10/2018 - 02/2002
13	Acute Lung Injury 11/2022 - 08/2003
13	Ischemia 01/2021 - 08/2003
11	Septic Shock (Toxic Shock Syndrome) 01/2022 - 04/2003
11	Critical Illness (Critically Ill) 01/2020 - 04/2003
10	Necrosis 11/2022 - 05/2008
9	Lung Injury 09/2017 - 12/2002
9	Smoke Inhalation Injury 08/2011 - 07/2003
8	Mitochondrial Diseases (Mitochondrial Disease) 01/2023 - 03/2012
8	Infarction (Infarctions) 12/2017 - 02/2002
8	Myocardial Ischemia (Ischemic Heart Diseases) 07/2014 - 02/2002
6	Down Syndrome (Down's Syndrome) 04/2024 - 01/2020
6	Atherosclerosis 01/2022 - 07/2008
6	Infections 01/2021 - 09/2002
5	Hypoxia (Hypoxemia) 11/2020 - 04/2008
5	Colorectal Neoplasms (Colorectal Cancer) 11/2017 - 04/2014
5	Diabetes Mellitus 01/2017 - 05/2002
5	Shock 03/2013 - 09/2002
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2012 - 09/2002
4	Hyperglycemia 12/2017 - 08/2011
4	Myocardial Infarction 12/2017 - 02/2002
4	Endotoxemia 02/2017 - 11/2006
4	Pulmonary Edema 02/2011 - 04/2008
4	Stroke (Strokes) 11/2009 - 12/2006
3	Breast Neoplasms (Breast Cancer) 04/2024 - 03/2023
3	Multiple Organ Failure (MODS) 12/2021 - 05/2009
3	Hypercholesterolemia 10/2018 - 12/2017
3	Hemorrhage 10/2018 - 06/2008
3	Wounds and Injuries (Trauma) 10/2018 - 02/2016
3	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 12/2013
3	Edema (Dropsy) 10/2011 - 12/2002
2	Neuroinflammatory Diseases 01/2023 - 12/2021
2	Brain Injuries (Brain Injury) 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

42	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 04/2024 - 09/2007
41	EnzymesIBA 04/2024 - 04/2003
29	CystathionineIBA 04/2024 - 08/2011
17	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2022 - 04/2003
15	LyasesIBA 10/2023 - 08/2011
15	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2022 - 04/2003
14	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2005
13	3-mercaptopyruvate sulphurtransferaseIBA 03/2023 - 02/2015
12	SmokeIBA 10/2018 - 07/2003
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 05/2002
10	Peroxidase (Myeloperoxidase)IBA 01/2020 - 06/2004
10	salicylhydroxamic acid (SHAM)IBA 10/2018 - 04/2008
9	Oxygen (Dioxygen)IBA 11/2020 - 11/2006
8	Adenosine Triphosphate (ATP)IBA 04/2024 - 11/2006
8	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 05/2002
8	NitrogenIBA 01/2019 - 07/2008
8	Poly Adenosine Diphosphate RiboseIBA 01/2015 - 02/2002
7	Aminooxyacetic AcidIBA 04/2024 - 07/2013
7	Ligases (Synthetase)IBA 01/2021 - 02/2002
7	Oxidants (Oxidizing Agents)IBA 01/2016 - 05/2002
6	olaparibIBA 01/2022 - 01/2017
6	Mitochondrial DNA (mtDNA)IBA 01/2021 - 10/2010
6	CytokinesIBA 11/2016 - 01/2005
6	Peroxynitrous Acid (Peroxynitrite)IBA 02/2011 - 07/2003
6	INO 1001IBA 05/2010 - 08/2003
5	Sulfides (Thioethers)IBA 01/2022 - 05/2008
5	3-nitrotyrosineIBA 01/2022 - 08/2003
5	GasotransmittersIBA 01/2021 - 03/2013
5	CreatinineIBA 01/2019 - 01/2016
5	LipopolysaccharidesIBA 02/2017 - 04/2003
5	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016 - 08/2011
5	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 06/2008 - 02/2002
4	Interleukin-6 (Interleukin 6)IBA 09/2022 - 05/2012
4	HMGB1 Protein (HMG1)IBA 01/2021 - 09/2009
4	Cystathionine beta-Synthase (Serine Sulfhydrase)IBA 01/2020 - 01/2016
4	Malondialdehyde (Propanedial)IBA 01/2020 - 01/2015
4	Urea (Carbamide)FDA LinkGeneric 01/2019 - 01/2016
4	Reactive Nitrogen SpeciesIBA 02/2011 - 07/2003
3	NF-kappa B (NF-kB)IBA 11/2022 - 05/2002
3	Interleukin-10 (Interleukin 10)IBA 09/2022 - 09/2008
3	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022 - 03/2013
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2013
3	ProdrugsIBA 01/2021 - 08/2012
3	Messenger RNA (mRNA)IBA 01/2021 - 10/2010
3	Phosphotransferases (Kinase)IBA 02/2020 - 10/2011
3	Amylases FDA Link 01/2020 - 11/2016
3	GYY 4137IBA 10/2018 - 05/2015
3	Nitric Oxide Synthase (NO Synthase)IBA 10/2017 - 05/2009
3	Free RadicalsIBA 11/2015 - 05/2002
3	ChemokinesIBA 05/2015 - 04/2008
3	AntioxidantsIBA 02/2015 - 04/2003
3	Evans Blue (Blue, Evans)FDA Link 05/2010 - 05/2008
3	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 03/2010 - 04/2008
3	EndotoxinsIBA 10/2003 - 12/2002
2	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2019

Therapy/Procedure

22	Therapeutics 08/2022 - 03/2005
10	Investigational Therapies (Experimental Therapy) 11/2022 - 05/2002
8	Ligation 01/2019 - 08/2003
5	Punctures 01/2019 - 03/2013
4	Resuscitation 01/2022 - 03/2009
4	Critical Care (Surgical Intensive Care) 10/2018 - 03/2009
4	Anesthesia 04/2012 - 01/2009